LO
Leighanne Oh
Investor at Ascenta Capital
LO
Leighanne Oh
Investor at Ascenta Capital
United States
Overview
Work Experience
Investor
2024 - Current
https://ascentacap.com/
Investor
2022 - 2024
Novo Holdings is a healthcare permanent capital fund investing in private and public companies, making it one of the most active life sciences venture capital investors globally. As of 2024, Novo Holdings was managing $147bn in total AUM with an annual capital deployment target of $3bn.
Investor
2019 - 2022
Founded in 1976, Sofinnova is a clinical-stage biopharmaceutical investment firm with approximately $3.0B in AUM and committed capital investing in both private and public equity of therapeutics-focused companies.
Healthcare Investment Banking
2017 - 2019
Advanced Manufacturing / Operations Engineer
2016 - 2016
MRI Gradient Coils and Shimming Optimization
Investment Banking Analyst
2014 - 2015
https://www.linkedin.com/pulse/owen-may-mba-83-lives-his-values-through-leadership-/
Howard Hughes Research Fellow
2009 - 2011
Research Analyst
2010 - 2011